Related Experiment Video
Updated: Feb 6, 2026

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
Published on: January 3, 2020
Subinhibitory Concentrations of Prim-O-Glucosylcimifugin Decrease the Expression of Alpha-Hemolysin in Staphylococcus
Ouyang Ping1, Yang Ruixue1, Deng Jiaqiang1
1College of Veterinary Medicine, Sichuan Agriculture University, Chengdu, China.
Abstract:
Staphylococcus aureus (S. aureus), an important opportunistic pathogen in human and animal, causes a series of diseases in the impairing of immunity of host and even then death. Alpha-hemolysin (Hla), a primary virulence factor, plays a major role in the pathogenic progress of S. aureus, especially in pneumonia. Prim-O-glucosylcimifugin (POG), a nature chromone compound, is an active ingredient in many Chinese Medicines. In this study, POG investigated the inhibitory effect of the secretion of Hla in S. aureus strain USA300 at the subinhibitory concentrations. The hemolysis assays and western blotting assays showed that POG can decrease the production of Hla in the USA300 growth cell cultures in a dose-dependent manner. The results of RT-PCR revealed that reduction of Hla was related to inhibit the transcription of hla and RNAIII. In the cells experiment, POG was proved to protect A549 cells from Hla-medicated injury. In conclusion, POG was shown the capacity of decreased the production of S. aureus Hla. POG can be developed as a candidate agent to treat S. aureus infections against Hla.
Insights
Prim-O-glucosylcimifugin (POG) reduces Staphylococcus aureus alpha-hemolysin (Hla) production and protects lung cells from injury. This natural compound shows potential for treating S. aureus infections by targeting Hla virulence.
Area of Science:
- Microbiology
- Pharmacology
- Molecular Biology
Background:
- Staphylococcus aureus (S. aureus) is a significant opportunistic pathogen causing severe human and animal diseases.
- Alpha-hemolysin (Hla) is a key virulence factor contributing to S. aureus pathogenicity, particularly in pneumonia.
- Prim-O-glucosylcimifugin (POG), a natural chromone compound from Chinese Medicine, is explored for its therapeutic potential.
Purpose of the Study:
- To investigate the inhibitory effect of Prim-O-glucosylcimifugin (POG) on alpha-hemolysin (Hla) secretion in Staphylococcus aureus.
- To evaluate POG's protective effects against Hla-mediated cellular injury.
Main Methods:
- Hemolysis and western blotting assays were used to assess Hla production.
- RT-PCR was employed to analyze the transcription of hla and RNAIII genes.
- Cell-based experiments using A549 cells were conducted to evaluate POG's protective capacity.
Main Results:
- POG significantly decreased Hla production in S. aureus USA300 in a dose-dependent manner.
- The reduction in Hla was associated with the inhibition of hla and RNAIII gene transcription.
- POG demonstrated a protective effect on A549 lung cells against Hla-induced damage.
Conclusions:
- Prim-O-glucosylcimifugin effectively reduces Staphylococcus aureus alpha-hemolysin production.
- POG inhibits Hla production by suppressing the transcription of key genes.
- POG shows promise as a potential therapeutic agent for treating S. aureus infections by targeting Hla.
More Related Videos
Related Concept Videos
Expressing Solution Concentration
Concentrations may be quantitatively assessed using a wide variety of measurement units, each convenient for particular applications. Molarity (M) is a useful concentration unit for many applications in chemistry.
Decreasing Function
Decreased Body Temperature
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Concentration and Rate Law
For example, in a generic reaction aA + bB ⟶ products, where a and b are stoichiometric coefficients, the rate law can be written as:
Concentration Cells
Consider the following voltaic cell:

